Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy.
In this retrospective analysis, the combination of Huaier granules and lenvatinib as postoperative adjuvant therapy was associated with improved long-term prognosis in patients at high risk of HCC recurrence.
Authors
- Maria A. Parra (ORCID: https://orcid.org/0009-0005-0951-2074)
- Haiyan Yang (ORCID: https://orcid.org/0000-0002-1371-3734)
- Haoling Liu (ORCID: https://orcid.org/0009-0007-2072-7492)
- Ying Bai (ORCID: https://orcid.org/0000-0002-7569-0099)
- Qingquan Bai (ORCID: https://orcid.org/0000-0003-0612-9801)
- Qian Cao (ORCID: https://orcid.org/0000-0002-1732-8817)
- Cong Liu (ORCID: https://orcid.org/0000-0001-6432-0511)
- Liangliang Zhao
- Jiashu Zou
Institutions
- Xiamen University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/jhc.s515730
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00